The US Blood Transfusion Diagnostics Market

The US Blood Transfusion Diagnostics Market

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

RELEASE DATE
10-Mar-2015
REGION
North America
Research Code: NE4E-01-00-00-00
SKU: LS00049-NA-MR_16890
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00049-NA-MR_16890

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Key Findings (continued)

Scope and Segmentation

Market Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

Key Companies to Watch (continued)

Executive Summary—2 Big Predictions

Executive Summary—2 Big Predictions (continued)

Executive Summary—2 Big Predictions (continued)

Market Background

Market Background—Types of Blood Bank Analyzers

Market Background—Types of Blood Bank Analyzers (continued)

Market Background—Types of Blood Bank Analyzers (continued)

Comparison of Immunohematology Methods

Voice of Customer—Factors Governing Equipment Purchase for a Transfusion Laboratory

Voice of Customer

Market Segmentation

Procurement Process

Defining Future Healthcare Trends

New Market Opportunities

New Market Opportunities (continued)

Market Drivers

Market Restraints

Market Impact of Top 6 Trends

Market Engineering Measurements

Market Engineering Measurements (continued)

Factors Impacting Market Forecasts

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening

Medicare Expenditure for Abo, Rh, and RBC Antigen Typing

Test Volume and Pricing Analysis for Blood Grouping Tests

Test Volume and Pricing Analysis for Blood Grouping Tests (continued)

Medicare Expenditure for Antibody Screening, Identification, and Cross Matching

Revenue Forecast

Revenue Forecast for Serological and Molecular

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Test Volume and Pricing Analysis for Disease Screening and NAT Tests

Test Volume Serological Donor Screening Tests

Test Volume Serological Donor Screening Tests (continued)

Cost Comparison per Test for Serological and NAT

Most Frequently Ordered Blood Tests by Rank

Accredited Immunohematology Reference Laboratories

Accredited Immunohematology Reference Laboratories (continued)

Accredited Immunohematology Reference Laboratories (continued)

Accredited Immunohematology Reference Laboratories (continued)

Accredited Immunohematology Reference Laboratories (continued)

Blood Transfusion Centers

Overview of Supply Chain in Blood Banks

Overview of Supply Chain in Blood Banks (continued)

Problem Areas and Solution

Market Share

Market Share Analysis

Product Analysis Blood Grouping

Product Analysis Blood Grouping (continued)

Product Analysis Disease Screening (Serological and Molecular)

Product Analysis Disease Screening (Molecular Assays)

Merger, Acquisition, and Partnership Assessment

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Immucor

Ortho Clinical Diagnostics

Beckman Coulter (Danaher)

BioRad

Quotient Limited (previously known as Alba Bioscience)

Immucor

Diagast

3Ti (Transfusion & Transplantation Technologies)

The Last Word—2 Big Predictions

The Last Word—Discussion

The Last Word—Discussion (continued)

Legal Disclaimer

Drivers Explained

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Additional Studies of Interest

Additional Studies of Interest (continued)

Market Engineering Methodology

Learn More—Next Steps

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.
More Information
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number NE4E-01-00-00-00
Is Prebook No